Layoffs at Fulcrum Therapeutics
- Layoff events
- 2
- verified and sourced
- Roles reported
- 77
- roles in total
- Announced between
- Sep 2024 to Jun 2026
- Reported by
- Fulcrum Therapeutics and U.S. Securities and Exchange Commission
This page records what we could verify and source. It is not a complete record of every job cut at Fulcrum Therapeutics: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Fulcrum Therapeutics |
Pipeline setback
Fulcrum Therapeutics disclosed an approximately 85% workforce reduction after discontinuing its lead clinical program and beginning a strategic review. |
48 | 84.2% | Company-wide |
2 sources for Fulcrum Therapeutics |
|
| Fulcrum Therapeutics |
Restructuring
Fulcrum Therapeutics announced a workforce reduction from 80 to 51 full-time employees as it reprioritized R&D activities. |
29 | 36.3% | United States |
1 source for Fulcrum Therapeutics |
Where this comes from
Every cut listed for Fulcrum Therapeutics was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Fulcrum Therapeutics? Tell us on our Discord and we will check it.